Screener
Bio-Rad Laboratories BIO Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Bio-Rad Laboratories’s reported figures.
Based on the most recent quarter.
The source filing: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026. Open the filing →
- Filed
- Apr 30, 2026, 4:19 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000012208-26-000035
FAQ
- What is Bio-Rad Laboratories's debt-to-equity?
- Bio-Rad Laboratories (BIO) reported debt-to-equity of 0.1× in Q1 2026.
- How has Bio-Rad Laboratories's debt-to-equity changed year-over-year?
- Bio-Rad Laboratories's debt-to-equity decreased by 30.2% year-over-year, from 0.2× to 0.1×.
- What is the long-term trend for Bio-Rad Laboratories's debt-to-equity?
- Over 5 years (2020 to 2025), Bio-Rad Laboratories's debt-to-equity has grown at a 51.0% compound annual growth rate (CAGR), from 0× to 0.2×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about Bio-Rad Laboratories's debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude